Cargando…

Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model

BACKGROUND: Application of latent variable models in medical research are becoming increasingly popular. A latent trait model is developed to combine rare birth defect outcomes in an index of infant morbidity. METHODS: This study employed four statewide, retrospective 10-year data sources (1999 to 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Xuerong, Hartzema, Abraham, Delaney, Joseph A., Brumback, Babette, Liu, Xuefeng, Egerman, Robert, Roth, Jeffrey, Segal, Rich, Meador, Kimford J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219655/
https://www.ncbi.nlm.nih.gov/pubmed/28061833
http://dx.doi.org/10.1186/s12884-016-1190-7
_version_ 1782492494974418944
author Wen, Xuerong
Hartzema, Abraham
Delaney, Joseph A.
Brumback, Babette
Liu, Xuefeng
Egerman, Robert
Roth, Jeffrey
Segal, Rich
Meador, Kimford J.
author_facet Wen, Xuerong
Hartzema, Abraham
Delaney, Joseph A.
Brumback, Babette
Liu, Xuefeng
Egerman, Robert
Roth, Jeffrey
Segal, Rich
Meador, Kimford J.
author_sort Wen, Xuerong
collection PubMed
description BACKGROUND: Application of latent variable models in medical research are becoming increasingly popular. A latent trait model is developed to combine rare birth defect outcomes in an index of infant morbidity. METHODS: This study employed four statewide, retrospective 10-year data sources (1999 to 2009). The study cohort consisted of all female Florida Medicaid enrollees who delivered a live singleton infant during study period. Drug exposure was defined as any exposure to Antiepileptic drugs (AEDs) during pregnancy. Mothers with no AED exposure served as the AED unexposed group for comparison. Four adverse outcomes, birth defect (BD), abnormal condition of new born (ACNB), low birth weight (LBW), and pregnancy and obstetrical complication (PCOC), were examined and combined using a latent trait model to generate an overall severity index. Unidimentionality, local independence, internal homogeneity, and construct validity were evaluated for the combined outcome. RESULTS: The study cohort consisted of 3183 mother-infant pairs in total AED group, 226 in the valproate only subgroup, and 43,956 in the AED unexposed group. Compared to AED unexposed group, the rate of BD was higher in both the total AED group (12.8% vs. 10.5%, P < .0001), and the valproate only subgroup (19.6% vs. 10.5%, P < .0001). The combined outcome was significantly correlated with the length of hospital stay during delivery in both the total AED group (Rho = 0.24, P < .0001) and the valproate only subgroup (Rho = 0.16, P = .01). The mean score for the combined outcome in the total AED group was significantly higher (2.04 ± 0.02 vs. 1.88 ± 0.01, P < .0001) than AED unexposed group, whereas the valproate only subgroup was not. CONCLUSIONS: Latent trait modeling can be an effective tool for combining adverse pregnancy and perinatal outcomes to assess prenatal exposure to AED, but evaluation of the selected components is essential to ensure the validity of the combined outcome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12884-016-1190-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5219655
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52196552017-01-10 Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model Wen, Xuerong Hartzema, Abraham Delaney, Joseph A. Brumback, Babette Liu, Xuefeng Egerman, Robert Roth, Jeffrey Segal, Rich Meador, Kimford J. BMC Pregnancy Childbirth Research Article BACKGROUND: Application of latent variable models in medical research are becoming increasingly popular. A latent trait model is developed to combine rare birth defect outcomes in an index of infant morbidity. METHODS: This study employed four statewide, retrospective 10-year data sources (1999 to 2009). The study cohort consisted of all female Florida Medicaid enrollees who delivered a live singleton infant during study period. Drug exposure was defined as any exposure to Antiepileptic drugs (AEDs) during pregnancy. Mothers with no AED exposure served as the AED unexposed group for comparison. Four adverse outcomes, birth defect (BD), abnormal condition of new born (ACNB), low birth weight (LBW), and pregnancy and obstetrical complication (PCOC), were examined and combined using a latent trait model to generate an overall severity index. Unidimentionality, local independence, internal homogeneity, and construct validity were evaluated for the combined outcome. RESULTS: The study cohort consisted of 3183 mother-infant pairs in total AED group, 226 in the valproate only subgroup, and 43,956 in the AED unexposed group. Compared to AED unexposed group, the rate of BD was higher in both the total AED group (12.8% vs. 10.5%, P < .0001), and the valproate only subgroup (19.6% vs. 10.5%, P < .0001). The combined outcome was significantly correlated with the length of hospital stay during delivery in both the total AED group (Rho = 0.24, P < .0001) and the valproate only subgroup (Rho = 0.16, P = .01). The mean score for the combined outcome in the total AED group was significantly higher (2.04 ± 0.02 vs. 1.88 ± 0.01, P < .0001) than AED unexposed group, whereas the valproate only subgroup was not. CONCLUSIONS: Latent trait modeling can be an effective tool for combining adverse pregnancy and perinatal outcomes to assess prenatal exposure to AED, but evaluation of the selected components is essential to ensure the validity of the combined outcome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12884-016-1190-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-06 /pmc/articles/PMC5219655/ /pubmed/28061833 http://dx.doi.org/10.1186/s12884-016-1190-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wen, Xuerong
Hartzema, Abraham
Delaney, Joseph A.
Brumback, Babette
Liu, Xuefeng
Egerman, Robert
Roth, Jeffrey
Segal, Rich
Meador, Kimford J.
Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model
title Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model
title_full Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model
title_fullStr Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model
title_full_unstemmed Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model
title_short Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model
title_sort combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219655/
https://www.ncbi.nlm.nih.gov/pubmed/28061833
http://dx.doi.org/10.1186/s12884-016-1190-7
work_keys_str_mv AT wenxuerong combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT hartzemaabraham combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT delaneyjosepha combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT brumbackbabette combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT liuxuefeng combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT egermanrobert combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT rothjeffrey combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT segalrich combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel
AT meadorkimfordj combiningadversepregnancyandperinataloutcomesforwomenexposedtoantiepilepticdrugsduringpregnancyusingalatenttraitmodel